In this study, we show that SNHG1 contributed to tumor progression and DDP resistance in breast cancer cells by inhibiting miR-381 expression through a novel epigenetic mechanism, highlighting an attractive therapeutic target to obstruct tumor progression and overcome breast cancer DDP resistance. Here, SNHG1 is linked to breast carcinoma.